These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 17346536

  • 1. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.
    Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC.
    Am J Obstet Gynecol; 2007 Mar; 196(3):239.e1-6. PubMed ID: 17346536
    [Abstract] [Full Text] [Related]

  • 2. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 3. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
    Asvold BO, Eskild A, Vatten LJ.
    Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
    [Abstract] [Full Text] [Related]

  • 4. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ, Åsvold BO, Eskild A.
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [Abstract] [Full Text] [Related]

  • 5. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
    Coolman M, Timmermans S, de Groot CJ, Russcher H, Lindemans J, Hofman A, Geurts-Moespot AJ, Sweep FC, Jaddoe VV, Steegers EA.
    Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
    [Abstract] [Full Text] [Related]

  • 6. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
    Unal ER, Robinson CJ, Johnson DD, Chang EY.
    Am J Obstet Gynecol; 2007 Aug; 197(2):211.e1-4. PubMed ID: 17689655
    [Abstract] [Full Text] [Related]

  • 7. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D, Biris D, Karampitsakos T, Nicolaides KK, Kametas NA.
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [Abstract] [Full Text] [Related]

  • 8. Circulating angiogenic proteins in trisomy 13.
    Bdolah Y, Palomaki GE, Yaron Y, Bdolah-Abram T, Goldman M, Levine RJ, Sachs BP, Haddow JE, Karumanchi SA.
    Am J Obstet Gynecol; 2006 Jan; 194(1):239-45. PubMed ID: 16389038
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM.
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [Abstract] [Full Text] [Related]

  • 12. Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.
    Woodham PC, Brittain JE, Baker AM, Long DL, Haeri S, Camargo CA, Boggess KA, Stuebe AM.
    Hypertension; 2011 Dec; 58(6):1120-5. PubMed ID: 21986503
    [Abstract] [Full Text] [Related]

  • 13. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
    Beck C, Allshouse A, Silver RM, Grobman WA, Simhan H, Haas D, Reddy UM, Blue NR.
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
    Odibo AO, Rada CC, Cahill AG, Goetzinger KR, Tuuli MG, Odibo L, Macones GA, England SK.
    J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
    [Abstract] [Full Text] [Related]

  • 16. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 17. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group.
    N Engl J Med; 2006 Sep 07; 355(10):992-1005. PubMed ID: 16957146
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
    Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV.
    Am J Obstet Gynecol; 2008 Sep 07; 199(3):266.e1-6. PubMed ID: 18771978
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.